Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Carbone

Showing results (171-180 of 283) with videos related to

Pageof 29
Sort By:
Journal for Immunotherapy of Cancer|June 19, 2022
Longitudinal plasma proteomic profiling of patients with non-small cell lung cancer undergoing immune checkpoint blockadeMichal Harel, Coren Lahav, Eyal Jacob, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 1, 2020
Verification of a Blood-Based Targeted Proteomics Signature for Malignant Pleural MesotheliomaFerdinando Cerciello, Meena Choi, Sara L Sinicropi-Yao, et al.
Lancet (London, England)|August 21, 2003
Proteomic patterns of tumour subsets in non-small-cell lung cancerKiyoshi Yanagisawa, Yu Shyr, Baogang J Xu, et al.
Lung Cancer (Amsterdam, Netherlands)|July 28, 2021
Real-world insights into patients with advanced NSCLC and MET alterationsMarisa Bittoni, James Chih-Hsin Yang, Jin-Yuan Shih, et al.
Cancer|March 3, 2005
Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinomaEric T Shinohara, Adriana Gonzalez, Pierre P Massion, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2015
Genomic Characterization of Non-Small-Cell Lung Cancer in African Americans by Targeted Massively Parallel SequencingLuiz H Araujo, Cynthia Timmers, Erica Hlavin Bell, et al.
JAMA Oncology|December 8, 2022
Association of Body Mass Index With the Safety Profile of Nivolumab With or Without IpilimumabJennifer L McQuade, Hans Hammers, Helena Furberg, et al.
Journal of Cancer Research and Clinical Oncology|August 2, 2019
Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancersMingjia Li, Daniel Spakowicz, Jarred Burkart, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 13, 2018
The Addition of Chemotherapy to Radiation Therapy Improves Survival in Elderly Patients with Stage III Non-Small Cell Lung CancerEric D Miller, James L Fisher, Karl E Haglund, et al.
Radiation Oncology (London, England)|October 7, 2018
Identifying patterns of care for elderly patients with non-surgically treated stage III non-small cell lung cancer: an analysis of the national cancer databaseEric D Miller, James L Fisher, Karl E Haglund, et al.
Pageof 29

Showing results (171-180 of 283) with videos related to

Sort By:
Pageof 29
Journal for Immunotherapy of Cancer|June 19, 2022
Longitudinal plasma proteomic profiling of patients with non-small cell lung cancer undergoing immune checkpoint blockadeMichal Harel, Coren Lahav, Eyal Jacob, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 1, 2020
Verification of a Blood-Based Targeted Proteomics Signature for Malignant Pleural MesotheliomaFerdinando Cerciello, Meena Choi, Sara L Sinicropi-Yao, et al.
Lancet (London, England)|August 21, 2003
Proteomic patterns of tumour subsets in non-small-cell lung cancerKiyoshi Yanagisawa, Yu Shyr, Baogang J Xu, et al.
Lung Cancer (Amsterdam, Netherlands)|July 28, 2021
Real-world insights into patients with advanced NSCLC and MET alterationsMarisa Bittoni, James Chih-Hsin Yang, Jin-Yuan Shih, et al.
Cancer|March 3, 2005
Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinomaEric T Shinohara, Adriana Gonzalez, Pierre P Massion, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2015
Genomic Characterization of Non-Small-Cell Lung Cancer in African Americans by Targeted Massively Parallel SequencingLuiz H Araujo, Cynthia Timmers, Erica Hlavin Bell, et al.
JAMA Oncology|December 8, 2022
Association of Body Mass Index With the Safety Profile of Nivolumab With or Without IpilimumabJennifer L McQuade, Hans Hammers, Helena Furberg, et al.
Journal of Cancer Research and Clinical Oncology|August 2, 2019
Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancersMingjia Li, Daniel Spakowicz, Jarred Burkart, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 13, 2018
The Addition of Chemotherapy to Radiation Therapy Improves Survival in Elderly Patients with Stage III Non-Small Cell Lung CancerEric D Miller, James L Fisher, Karl E Haglund, et al.
Radiation Oncology (London, England)|October 7, 2018
Identifying patterns of care for elderly patients with non-surgically treated stage III non-small cell lung cancer: an analysis of the national cancer databaseEric D Miller, James L Fisher, Karl E Haglund, et al.
Pageof 29